Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07315997 · ClinicalTrials.gov registry record
The Coronary Artery Calcium and Troponins in Rheumatoid Arthritis (CAT-RA) Study
A clinical trial of Rheumatoid Arthritis (RA) and Atherosclerotic Cardiovascular Disease (ASCVD), sponsored by Brigham and Women's Hospital.
- Recruiting
- Registry status
- 120
- Enrollment target
- 1
- Study location
NCT07315997: Recruiting study of Rheumatoid Arthritis (RA) and Atherosclerotic Cardiovascular Disease (ASCVD), sponsored by Brigham and Women's Hospital.
NCT07315997 is a study of Rheumatoid Arthritis (RA) and Atherosclerotic Cardiovascular Disease (ASCVD) that is actively recruiting participants, run by Brigham and Women's Hospital. The registered enrollment target is 120 participants, below the 261-participant average among 17 other Rheumatoid Arthritis (RA) trials with a reported enrollment target (54% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07315997, a study of Rheumatoid Arthritis (RA) and Atherosclerotic Cardiovascular Disease (ASCVD), is actively recruiting participants, sponsored by Brigham and Women's Hospital.
- RECRUITING
- Registry status
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
Individuals with rheumatoid arthritis (RA) have up to 2x the risk of having a heart attack compared to someone without RA. The goal of this study is to identify biomarkers that can help us do a better job of identifying individuals at risk before they develop symptoms of heart disease and start preventative treatment earlier.
Primary Outcome
Quantified coronary artery calcium score
Conditions Studied
Interventions
- DIAGNOSTIC_TEST high sensitivity cardiac troponin
Study Locations (1)
Massachusetts
- Brigham and Womens Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2024-09-04 |
| Est. Completion | 2028-03-04 |
What NCT07315997 shows while recruiting
NCT07315997 is an observational study that tracks outcomes without assigning an intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 261-participant average among 17 other Rheumatoid Arthritis (RA) trials with a reported enrollment target (54% lower).
The record links to 2 conditions, with Rheumatoid Arthritis (RA) appearing as the primary indexed condition, and to 1 intervention - of which high sensitivity cardiac troponin is the first listed.
NCT07315997 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT07315997 about?
NCT07315997 is a clinical study titled "The Coronary Artery Calcium and Troponins in Rheumatoid Arthritis (CAT-RA) Study". Individuals with rheumatoid arthritis (RA) have up to 2x the risk of having a heart attack compared to someone without RA. The goal of this study is to identify biomarkers that can help us do a better job of identifying individuals at risk before they develop symptoms of heart disease and start prev...
What is the current status of trial NCT07315997?
This trial is currently recruiting. The enrollment target is 120 participants. The study started on 2024-09-04. Estimated completion is 2028-03-04.
What conditions does trial NCT07315997 study?
This clinical trial studies the following conditions: Rheumatoid Arthritis (RA), Atherosclerotic Cardiovascular Disease (ASCVD).
What interventions are being tested in trial NCT07315997?
The interventions under investigation include: high sensitivity cardiac troponin (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT07315997?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07315997 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Rheumatoid Arthritis (RA)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07315997's enrollment target sits among peer trials
120 7th of 17 higher than 11 of 17 other Rheumatoid Arthritis (RA) trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Rheumatoid Arthritis (RA) trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
At-home Ultrasound Localized Therapy for Rheumatoid Arthritis Study [At-home ULTRA Study]
RECRUITING · NA
-
Probiotics in Adults With Rheumatoid Arthritis
RECRUITING · NA
-
Dose Response of Exercise for Arthritis Management
RECRUITING · NA
-
A Dose Response Study to Evaluate the Efficacy and Safety of Oral AP1189 Administered in Disease-Modifying Anti-Rheumatic Drug (DMARD) naïve Participants Participants With Early Rheumatoid Arthritis
RECRUITING · Phase 2
-
A Study of LY4213663 in Healthy Participants and Participants With Rheumatoid Arthritis
RECRUITING · Phase 1
-
A Long-Term Follow-Up Study for Participants Previously Treated With KYV-101
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI